Evidence map›Paper›PMID 30651544›Full record

ArticleNature communications2019

Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice.

Raffaella Rossin, Ron M Versteegen, Jeremy Wu, Alisher Khasanov, Hans J Wessels, Erik J Steenbergen, Wolter Ten Hoeve, Henk M Janssen, Arthur H A M van Onzen, Peter J Hudson and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Raffaella RossinTagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Ron M VersteegenSyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands.
Jeremy WuAvipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia.
Alisher KhasanovLevena Biopharma, 4955 Directors Place, Suite 300, San Diego, CA, 92121, USA.
Hans J WesselsRadboud Proteomics Centre, Department of Laboratory Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Erik J SteenbergenDepartment of Pathology, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Wolter Ten HoeveSyncom B.V., Kadijk 3, 9747 AT, Groningen, The Netherlands.
Henk M JanssenSyMO-Chem B.V., Den Dolech 2, 5612 AZ, Eindhoven, The Netherlands.
Arthur H A M van OnzenTagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Peter J HudsonAvipep Pty Ltd, 343 Royal Parade, Parkville, VIC, 3052, Australia.
Marc S RobillardTagworks Pharmaceuticals, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. marc.robillard@tagworkspharma.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this Article omitted the following from the Acknowledgements: 'This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program under Award No. W81XWH-15-1-0692. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense'. This error has now been corrected in the PDF and HTML versions of the Article.

Identifiers

PMID30651544
PMCPMC6335410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.